BOLT Bolt Biotherapeutics Inc. Year-over-year net earnings per share growth for the last 12 months
Bolt Biotherapeutics is currently revising its strategy, focusing on accelerating tests for its primary oncology drug under a cost-saving regime. The company is attracting leading immunologists by leveraging patents and options. The quarterly change in earnings per share on the GURU.Markets terminal linear chart contains the point 39.70, which defines the current value of the indicator. The firm's technological foundation consists of automated laboratory complexes for biological testing.
Financial and market metric breakdowns for Bolt Biotherapeutics (BOLT)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Bolt Biotherapeutics|BOLT - Long-Term Debt to Equity|Short-Term Debt to Equity boltbio.com|BOLT - Company Cumulative Debt|Debt to Book Capitalization Ratio Bolt Bio|BOLT - Company Long-Term Debt|Company Current Liabilities Bolt Biotherapeutics|Quick Liquidity Indicator boltbio.com
- earnings and market multiples details:
BOLT - Final Profit|Projected Future Earnings Bolt Biotherapeutics|BOLT - Price to Earnings Ratio|Forward P/E Multiple boltbio.com|BOLT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Bio|BOLT - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Bolt Biotherapeutics|BOLT - Earnings per share for the last four quarters|Quarterly EPS earnings growth boltbio.com|BOLT - Earnings per share increase in current year|Earnings growth forecast for next year Bolt Biotherapeutics
- company sales and revenue statistics:
Comprehensive company analysis:Bolt Biotherapeutics
Effective cost management and the patent protection implemented by Bolt Biotherapeutics (BOLT) are reflected in the quarterly EPS trend profile, which captures the percentage growth of net income per share. This indicator measures the fundamental momentum between reports, allowing investors to determine the return vector through the analysis of daily fluctuations and timely identify peak profit points within the high-risk biotech sector.
Direct competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|CLDX: Year-over-year earnings per share growth for the last twelve months|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months biocryst.com (BCRX)|Year-over-year earnings per share growth for the last twelve months Vera Therapeutics|Year-over-year earnings per share growth for the last twelve months DNTH|Year-over-year net earnings per share growth for the last 12 months PHVS (Pharvaris Corp)|Year-over-year earnings per share growth rate for the last twelve months ABCL|Tourmaline Bio, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PGEN|Pharming Group - Quarterly EPS earnings growth|NKTR: Year-over-year earnings per share growth for the last twelve months|UPB: Quarterly EPS earnings growth|ZBIO - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Immunome, Inc.|Earnings per share growth in annualized terms for the last twelve months gossamerbio.com GOSS|Year-over-year net earnings per share growth for the last 12 months KALV (KalVista Pharmaceuticals, Inc.)|Year-over-year earnings per share growth rate for the last twelve months SEPN|Quarterly EPS earnings growth PVLA (Pieris Pharmaceuticals Inc)|Year-over-year earnings per one share growth for the last 12 months SVRA|Rigel Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months anaptysbio.com|Astria Therapeutics, Inc. (ATXS) - Year-over-year earnings per share growth for the last twelve months|enGene Holdings Inc - Year-over-year earnings per one share growth for the last 12 months|RAPT (RAPT Therapeutics) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Aerovate|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|KYTX: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth TLSA (Tiziana Life Sciences Ltd)|Cabaletta Bio Inc. (CABA) - Earnings per share growth in annualized terms for the last twelve months|VTYX: Year-over-year net earnings per share growth for the last 12 months|THTX - Quarterly EPS earnings growth|AVTX (Avalo Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|ELDN: Year-over-year earnings per share growth rate for the last twelve months|AGEN (Agenus Inc.) - Quarterly EPS earnings growth|Climb Bio Inc. (CLYM) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth ZURA|Year-over-year net earnings per share growth for the last 12 months aTyr Pharmaceuticals ATYR|Year-over-year earnings per share growth for the last twelve months Adagene Inc. ADAG|Year-over-year net earnings per share change for the last twelve months ImageneBio (IMA)|Shattuck Therapeutics - Quarterly EPS earnings growth|EQ: Year-over-year earnings per share growth for the last twelve months|connectbiopharm.com (CNTB) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Immunic (IMUX)|Year-over-year earnings per share growth for the last twelve months Atara Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last twelve months IFRX|Year-over-year net earnings per share growth for the last 12 months XFOR (X4 Pharmaceuticals, Inc.)|Year-over-year earnings per share growth rate for the last twelve months ACET|Year-over-year earnings per share growth for the last twelve months Celularity CELU|INMB (INmune Bio Corporation) - Year-over-year net earnings per share trend for the last twelve months|Barinthus Biotherapeutics - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months KZR (kezarlifesciences.com)|SABS: Quarterly EPS earnings growth|Akari Therapeutics PLC (AKTX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Enlivex Therapeutics Ltd|QTTB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months GeoVax Labs, Inc. (GOVX)|Year-over-year net earnings per share growth for the last 12 months edesabiotech.com EDSA|Quarterly EPS earnings growth IBIO (iBio)|Quarterly EPS earnings growth Carisma Therapeutics Inc CARM|XTLB: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HCWB (HCW Biologics Inc.)|APVO: Quarterly EPS earnings growth|AIM - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Aditxt Inc.|Year-over-year net earnings per share growth for the last 12 months GRI Bio Inc (GRI)|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Year-over-year net earnings per share growth for the last 12 months Vyome Therapeutics HIND|Revelation Biosciences - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth indaptusrx.com INDP|SCNI - Year-over-year earnings per share growth for the last twelve months|CALI (CalciMedica, Inc.) - Year-over-year earnings per share growth for the last 12 months|AFMD: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Allakos (ALLK)|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months IGMS|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|OCEA - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months TC BioPharm (Holdings) PLC TCBP|Third Harmonic Bio Inc - Year-over-year earnings per share growth for the last twelve months
